Figure 3
From: Entinostat as a combinatorial therapeutic for rhabdomyosarcoma
Concentration–time profiles of entinostat in mice (n = 3) treated with multiple doses of 4 mg/kg administered orally once daily. Plasma was obtained at timepoints over 24 h after a single dose as well as prior to the daily dose on Day 4 (72 h) and Day 5 (96 h). Data points and error bars represent mean and SD of 3 replicates, respectively.
